Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
5’094 JPY | +1.35% | -1.76% | -4.64% |
25.04. | Muttergesellschaft von Chugai Pharmaceutical, Roche, verzeichnet geringere Verkäufe in Q1; Aktie fällt um 5% | MT |
24.04. | Gewinn von Chugai Pharmaceutical in Q1 leicht gestiegen | MT |
ETFs investiert in Chugai Pharmaceutical Co., Ltd
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
0,08% | 7 M€ | +2.57% | - | |
0,08% | 277 M€ | -.--% | - | |
0,08% | 194 M€ | +7.33% | - | |
0,08% | 441 M€ | +9.08% | ||
0,07% | 7 M€ | +0.11% | - | |
0,07% | 276 M€ | +11.40% | - | |
0,06% | 205 M€ | -.--% | ||
0,05% | 284 M€ | -.--% | ||
0,05% | 31 M€ | +4.25% | - | |
0,05% | 0 M€ | 0.00% | - | |
0,04% | 786 M€ | -.--% | ||
0,04% | 23 M€ | -.--% | - | |
0,04% | 206 M€ | -.--% | ||
0,03% | 1 166 M€ | +0.26% | - | |
0,03% | 607 M€ | +0.05% | - | |
0,03% | 34 M€ | +6.29% | - | |
0,03% | 389 M€ | +6.29% | - | |
0,02% | 34 M€ | +2.04% | - | |
0,02% | 39 M€ | +4.22% | - | |
0,02% | 302 M€ | +4.05% | - | |
0,01% | 17 M€ | +1.40% | - | |
0,01% | 108 M€ | +1.89% | - | |
0,01% | 147 M€ | +4.63% | - | |
0,01% | 8 M€ | -0.30% | - | |
0,01% | 52 M€ | -0.41% | - | |
0,01% | 237 M€ | +0.55% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-4.64% | 52.47 Mrd. | |
+29.68% | 699 Mrd. | |
+25.07% | 571 Mrd. | |
-4.35% | 364 Mrd. | |
+17.65% | 326 Mrd. | |
+3.77% | 286 Mrd. | |
+14.68% | 236 Mrd. | |
+4.71% | 198 Mrd. | |
-12.43% | 194 Mrd. | |
-3.79% | 154 Mrd. |
- Börse
- Aktien
- 857216 Aktie
- ETFs Chugai Pharmaceutical Co., Ltd